Full history for every metric is available with a Kvantra account
SMS Lifesciences India Limited (SMSLIFE.NS)
Key financial summary
Financials in INR| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | INR m | 2,656 | 3,473 | 3,156 | 3,060 | 3,447 | 3,338 | 3,338 |
| Operating profit | INR m | 292 | 280 | |||||
| Net profit | INR m | 136 | 253 | 115 | 91 | 201 | 173 | 173 |
| EPS reported | INR | 57.26 | 57.27 | |||||
| Operating cashflow per share | INR | 115.7 | 99.19 | |||||
| Capex per share | INR | 191.4 | 37.81 | |||||
| FCF per share | INR | -75.74 | 61.38 | |||||
| Free cash flow | INR m | -229 | 186 | |||||
| Net debt | INR m | 1,074 | 1,082 | |||||
| Book value equity | INR m | 2,135 | 2,135 | |||||
| Book value per share | INR | 706.4 | 705.7 | |||||
| Number of shares | m | 3.02 | 3.03 | |||||
| DPS (TTM paid) | INR | 1.50 | 1.50 |
Financial summary
Financials in INR| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 20.85 | 26.43 | |||||
| P/B LTM | x | 1.93 | 1.84 | |||||
| P/S LTM | x | 1.23 | 1.18 | |||||
| P/FCF LTM | x | -17.98 | 21.14 | |||||
| EV/EBITDA LTM | x | 11.63 | 11.15 | |||||
| EV/Sales LTM | x | 1.56 | 1.50 | |||||
| Earnings Yield LTM | % | 4.80% | 3.78% | |||||
| FCF Yield | % | -5.56% | 4.73% | |||||
| Quality | ||||||||
| ROE | % | 8.11% | 8.36% | |||||
| ROIC | % | 5.77% | 5.53% | |||||
| Operating margin | % | 8.75% | 8.40% | |||||
| Gross margin | % | 14.38% | 19.76% | |||||
| FCF/Sales | % | -6.86% | 5.56% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | -13.92% | -13.92% | |||||
| Sales Growth YoY | % | -3.17% | -3.17% | |||||
| Net Income Growth YoY | % | -13.91% | -13.91% | |||||
| FCF Growth | % | - | +149.27% | |||||
| Operating Profit Growth | % | -2.78% | -2.78% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.11% | 0.12% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | 2.62% | 2.62% | |||||
| FCF/Debt | x | -0.21 | 0.17 | |||||
| Net Debt/EBITDA | x | 2.42 | 2.41 | |||||
| EBIT/Net interest | x | 4.53 | 4.35 | |||||
| Net debt/market cap | % | 26.08% | 27.54% | |||||
| Net debt/Equity | x | 0.50 | 0.51 | |||||
| Gross debt/equity | x | 0.52 | 0.52 | |||||
Company overview
SMS Lifesciences India Limited is a pharmaceutical enterprise engaged in the manufacturing, sourcing, importing, and distribution of active drug components (APIs) along with their intermediates, various organic and inorganic chemicals, and finished pharmaceutical products across the Indian market. The company's API offerings cater to a range of medical conditions, encompassing therapeutic areas such as antiulcer treatments, antifungal medications, and solutions for erectile dysfunction. Beyond its product line, the firm also provides expert consultancy services. Its reach extends beyond national borders, as it actively exports its diverse product range. Established in 1990, the company's main operations are based in Hyderabad, India.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
SMS Lifesciences India Limited (SMSLIFE.NS)
SMS Lifesciences India Limited is a pharmaceutical enterprise engaged in the manufacturing, sourcing, importing, and distribution of active drug components (APIs) along with their intermediates, various organic and inorganic chemicals, and finished pharmaceutical products across the Indian market. The company's API offerings cater to a range of medical conditions, encompassing therapeutic areas such as antiulcer treatments, antifungal medications, and solutions for erectile dysfunction. Beyond its product line, the firm also provides expert consultancy services. Its reach extends beyond national borders, as it actively exports its diverse product range. Established in 1990, the company's main operations are based in Hyderabad, India.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free